BUSINESS STANDARD Malawi to undertake the RTS


  • Malawi, the African Nation, is to undertake large scale pilot tests for the world’s most advanced experimental malaria vaccine in a bid to prevent the disease.
  • The RTS, S vaccine, the first to give partial protection to children, trains the immune system to attack the malaria parasite.
  • RTS, S vaccine under the trade name Mosquirix has been developed by GlaxoSmithKline.
Share Socially